• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Heart Failure Society of America (HFSA) 16th Annual Scientific Meeting - Review and Analysis - Product Image

Heart Failure Society of America (HFSA) 16th Annual Scientific Meeting - Review and Analysis

  • ID: 2258801
  • September 2012
  • Region: America, United States
  • 20 pages
  • GlobalData

Heart Failure Society of America (HFSA) 16th Annual Scientific Meeting - Review and Analysis

Summary

Our report, “Heart Failure Society of America (HFSA) 16th Annual Scientific Meeting - Review and Analysis” provides key information, analysis and companies with their exhibited products at the HFSA 2012 Conference. The report provides the highlights of the meeting, presentations and key participants with description on their exhibited products.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Key players and their exhibited products.
- Qualitative analysis on key research presentations.

Reasons to buy

- Develop business strategies by understanding the activities and developments at ECR 2012 Conference that can have an impact on the market.
- Design and develop your product development, marketing and sales strategies
- Exploit M&A opportunities by identifying key market players and their products
- Develop market-entry and market expansion strategies
- Identify key players best positioned to take advantage of the market opportunities

1
1

2 Summary
3 Heart Failure Society of America (HFSA) 16th Annual Scientific Meeting Highlights
3.1 CircuLite Synergy System Shows Positive Results for Circulatory Support for Elderly Chronic Heart Failure Patients
3.1.1 Conclusions and Significance
3.2 CircuLite Synergy System Improves Hemodynamics and Exercise Tolerance in Chronic Ambulatory Heart Failure
3.2.1 Conclusions and Significance
3.3 Cardiac Resynchronization Therapy (CRT) Device Diagnostics can Help Predict Rehospitalization Rate
3.3.1 Conclusions and Significance
3.4 Cardiac Resynchronization Therapy Optimization Through CardioSync Methodology Compared to Echocardiographic Methodology Found to be Effective in Improving Patient Outcomes
3.4.1 Conclusions and Significance
3.5 Cardiac Resynchronization Therapy is Beneficial to Patients with Mild to Moderate Heart Failure
3.5.1 Conclusions and Significance
3.6 Percutaneous Mechanical Support Devices Improve Outcomes for Patients Suffering from Cardiogenic Shock
3.6.1 Conclusions and Significance
3.7 Researchers find Continuous Flow Pump Therapy Prone to High Rate of Readmission due to Complications
3.7.1 Conclusions and Significance
4 Key Companies and their Products
4.1 ZOLL Medical Corporation
4.1.1 LifeVest
4.2 Thoratec Corporation
4.2.1 HeartMate II LVAS
4.2.2 CentriMag
4.2.3 PediMag
4.3 HeartWare, Inc.
4.3.1 HeartWare Ventricular Assist System (VAS)
4.4 SynCardia Systems, Inc.
4.4.1 SynCardia Temporary Total Artificial Heart
4.5 CardiacAssist, Inc.
4.5.1 TandemHeart System
4.6 BG Medicine, Inc.
4.6.1 BGM Galectin-3 Test
4.7 Shape Medical Systems, Inc.
4.7.1 Shape-HF
4.8 XDx, Inc.
4.8.1 AlloMap
5 Appendix
5.1 Acronyms
5.2 Sources
5.3 Research Methodology
5.4 Secondary Research
5.5 Primary Research
5.6 Models
5.7 Forecasts
5.8 Expert Panels
5.9 Consulting
5.10 Contact Us
5.11 Disclaimer

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos